Skip to main content
. 2021 Dec 29;14(1):76. doi: 10.3390/pharmaceutics14010076
AMP antimicrobial peptide
APTES (3-aminopropyl)-triethoxysilane
Asp asparagine
BBT bromelain-based treatment
CDTA cyclohexane-1,2-diaminoetetraacetic acid
COX-2 prostaglandin-endoperoxide synthase 2
CP cysteine proteinase
DETA diethylenetriamine
Dha dehydroalanine
Dhb dehydrobutyrine
ECM extracellular matrix
EDC 1-ethyl-(3-dimethylaminopropyl) carbodiimide
EDTA ethylenediaminetetraacetic acid
EMA European Medicines Agency
GA glutaraldehyde
HEDTA hydroxyethyl ethylenediamine triacetic acid
IL interleukin
Lan lanthionine
LD50 lethal dose
Leu leucine
Km Michaelis–Menten constant
MBC minimum bactericidal concentration
MeLan β-methyl lanthionine
MIC minimum inhibitory concentration
MRSA methicillin-resistant Staphylococcus aureus
MSN mesoporous silica nanoparticles
NCBI National Center for Biotechnology Information
NF-κB Nuclear factor kappa B
NHS N-hydroxysuccinimide
PC phosphatidylcholine
PEG poly(ethylene glycol)
PEHA pentaethylenehexamine
PET polyethylene terephthalate
PGE-2 prostaglandin E2
PGI-2 prostaglandin I2
pI isoelectric point
PS polystyrene
SEM scanning electron microscopy
SPRA self-assembly PEGylation retaining activity
TEPA tetraethylenepentamine
TETA triethylenetetramine
TNF tumour necrosis factor
TXA-2 thromboxane A2
Vmax maximum reaction velocity
Val valine